BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 19593165)

  • 1. Adalimumab-induced autoimmune hepatitis.
    Adar T; Mizrahi M; Pappo O; Scheiman-Elazary A; Shibolet O
    J Clin Gastroenterol; 2010 Jan; 44(1):e20-2. PubMed ID: 19593165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoimmune hepatitis induced by adalimumab with successful switch to abatacept.
    Grasland A; Sterpu R; Boussoukaya S; Mahe I
    Eur J Clin Pharmacol; 2012 May; 68(5):895-8. PubMed ID: 22205272
    [No Abstract]   [Full Text] [Related]  

  • 3. Autoimmune hepatitis induced by infliximab in a patient with Crohn's disease with no relapse after switching to adalimumab.
    Cravo M; Silva R; Serrano M
    BioDrugs; 2010 Dec; 24 Suppl 1():25-7. PubMed ID: 21175232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Acute drug-induced hepatitis during adalimumab and ibuprofen treatment].
    Féau S; Causse X; Corondan A; Michenet P; Autret-Leca E
    Gastroenterol Clin Biol; 2010; 34(6-7):420-2. PubMed ID: 20494537
    [No Abstract]   [Full Text] [Related]  

  • 5. Autoimmune hepatitis triggered by adalimumab and allergic reactions after various anti-TNFα therapy agents in a patient with rheumatoid arthritis.
    Petríková J; Jarčuška P; Svajdler M; Pella D; Macejová Z
    Isr Med Assoc J; 2015 Apr; 17(4):256-8. PubMed ID: 26040057
    [No Abstract]   [Full Text] [Related]  

  • 6. Autoimmune hepatitis after long-term methotrexate therapy for rheumatoid arthritis.
    Moreno-Otero R; García-Buey L; García-Sanchez A; Trapero-Marugán M
    Curr Drug Saf; 2011 Jul; 6(3):197-200. PubMed ID: 22122395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exacerbation of psoriatic skin lesions in a patient with psoriatic arthritis receiving adalimumab.
    Borrás-Blasco J; Gracia-Perez A; Nuñez-Cornejo C; Rosique-Robles JD; Mateu-Puchades A; Casterá MD; Rubio-Fabra M
    J Clin Pharm Ther; 2008 Jun; 33(3):321-5. PubMed ID: 18452420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adalimumab in juvenile rheumatoid arthritis.
    Taddio A; Marchetti F
    N Engl J Med; 2008 Dec; 359(23):2495-6; author reply 2496-7. PubMed ID: 19065749
    [No Abstract]   [Full Text] [Related]  

  • 9. Autoimmune hepatitis associated with infliximab in a patient with psoriatic arthritis.
    Germano V; Picchianti Diamanti A; Baccano G; Natale E; Onetti Muda A; Priori R; Valesini G
    Ann Rheum Dis; 2005 Oct; 64(10):1519-20. PubMed ID: 16162908
    [No Abstract]   [Full Text] [Related]  

  • 10. Adalimumab for long-term treatment of psoriatic arthritis: forty-eight week data from the adalimumab effectiveness in psoriatic arthritis trial.
    Gladman DD; Mease PJ; Ritchlin CT; Choy EH; Sharp JT; Ory PA; Perdok RJ; Sasso EH
    Arthritis Rheum; 2007 Feb; 56(2):476-88. PubMed ID: 17265483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoimmune hepatitis as an adverse effect of long-term methotrexate therapy.
    Ksouda K; Affes H; Atheymen R; Ezzeddine M; Zeghal K; Hammami S
    Indian J Pharmacol; 2014; 46(6):649-50. PubMed ID: 25538339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adalimumab-associated multiple sclerosis.
    Bensouda-Grimaldi L; Mulleman D; Valat JP; Autret-Leca E
    J Rheumatol; 2007 Jan; 34(1):239-40; discussion 240. PubMed ID: 17216704
    [No Abstract]   [Full Text] [Related]  

  • 13. Use of adalimumab in treatment of autoimmune sensorineural hearing loss: a word of caution.
    Conway R; Khan S; Foley-Nolan D
    J Rheumatol; 2011 Jan; 38(1):176; author reply 176. PubMed ID: 21196585
    [No Abstract]   [Full Text] [Related]  

  • 14. Adalimumab: human recombinant immunoglobulin g1 anti-tumor necrosis factor monoclonal antibody.
    Baker DE
    Rev Gastroenterol Disord; 2004; 4(4):196-210. PubMed ID: 15580154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hepatitis-B reactivation during treatment with tumor necrosis factor-α blocker adalimumab in a patient with psoriasis arthritis].
    Kouba M; Rudolph SE; Hrdlicka P; Zuber MA
    Dtsch Med Wochenschr; 2012 Jan; 137(1-2):23-6. PubMed ID: 22180279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alopecia areata universalis elicited during treatment with adalimumab.
    Pelivani N; Hassan AS; Braathen LR; Hunger RE; Yawalkar N
    Dermatology; 2008; 216(4):320-3. PubMed ID: 18230980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of herpes zoster in patients with rheumatoid arthritis treated with anti-TNF-alpha agents.
    Strangfeld A; Listing J; Herzer P; Liebhaber A; Rockwitz K; Richter C; Zink A
    JAMA; 2009 Feb; 301(7):737-44. PubMed ID: 19224750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A case of adalimumab-associated interstitial pneumonia with rheumatoid arthritis.
    Yamazaki H; Isogai S; Sakurai T; Nagasaka K
    Mod Rheumatol; 2010 Oct; 20(5):518-21. PubMed ID: 20467775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Should we be afraid of the anti-TNFalpha drugs in 2008?].
    Gaudin P
    Rev Med Interne; 2008 Dec; 29(12):971-4. PubMed ID: 18571291
    [No Abstract]   [Full Text] [Related]  

  • 20. Interstitial granulomatous dermatitis associated with the use of tumor necrosis factor alpha inhibitors.
    Deng A; Harvey V; Sina B; Strobel D; Badros A; Junkins-Hopkins JM; Samuels A; Oghilikhan M; Gaspari A
    Arch Dermatol; 2006 Feb; 142(2):198-202. PubMed ID: 16490847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.